Market Overview
Generative
AI in Healthcare Market is projected to achieve a value of USD 3,753 Million in
2023, with a linear behavior in the market growth it is forecasted to achieve a
value of USD 24,218 Million by 2033 with a CAGR of 37.2% during the forecast
period 2024-2033.
Generative
artificial intelligence, a subfield of AI that employs algorithms to generate
fresh videos, images, and text that closely resemble its source data, is
rapidly proliferating. This technology sets itself apart from other AI
approaches by utilizing predictive models to anticipate outcomes based on
previously collected patient data. In contrast to conventional AI, which
primarily centers on pattern recognition, decision-making, data analysis, and
data categorization, genAI produces original content, chat responses, designs,
and synthetic data.
These
innovative methods hold the promise of revolutionizing multiple facets of
healthcare, encompassing diagnostics, disease prognosis, drug development, and
patient treatment. Generative AI is based on the framework of Generative
Adversarial Networks (GANs), which comprise two key elements: a generator
network and a discriminator network. The generator network is instructed to
create synthetic data, including medical images, patient records, or molecular
structures, while the discriminator network endeavors to differentiate between
genuine and generated data. Through an iterative and competitive process, these
networks enhance their capabilities, ultimately producing data that is both
remarkably authentic and valuable.
Furthermore,
genAI extends its utility beyond mere diagnosis and assumes a pivotal role in
recommending personalized treatment solutions. Leveraging extensive medical
databases and cutting-edge research, this technology can suggest evidence-based
treatments and interventions, thereby guaranteeing that patients benefit from
the most efficacious and tailored care. As genAI advances, its capacity to
transform clinical decision-making is indisputable. Primary care providers now
possess a valuable partner capable of sifting through extensive data,
identifying trends, and providing invaluable insights that ultimately culminate
in enhanced patient outcomes.
Generative
AI in Healthcare Market having several factors are propelling the market
growth, encompassing the expanding accessibility of substantial healthcare data
sets, the heightened need for personalized and precision medicine, the surging
incidence of chronic illnesses, and the growing integration of artificial
intelligence in the healthcare sector.
The
COVID-19 pandemic has exerted a favorable influence on the generative AI in
healthcare market, driven by the heightened need for generative AI solutions in
drug discovery and vaccine development. Researchers have harnessed generative
AI to create novel drug candidates and pinpoint potential vaccine targets. For
Instance, Scientists at the University of Toronto employed generative AI to
create an innovative antibiotic capable of combating drug-resistant bacteria.
Market Scope
Report Attributes |
Description |
Market Size in 2023 |
USD 3753 Million |
Market Forecast in 2033 |
USD 24,218
 Million |
CAGR % 2024-2033 |
37.2% |
Base Year |
2023 |
Historic Data |
2016-2022 |
Forecast Period |
2024-2033 |
Report USP |
Production,
Consumption, company share, company heatmap, company production capacity,
growth factors and more |
Segments Covered |
By Function, By Application, By End User
and By Region |
Growth Drivers |
AI-driven
generative models can enhance the accuracy and efficiency of medical image
analysis, including the detection and classification of diseases in radiology
and pathology images. NLP-powered generative AI can extract valuable information from unstructured clinical notes, patient records, and medical literature, improving data analysis and supporting medical research. AI-powered chatbots and virtual healthcare assistants can provide remote patient monitoring and telemedicine services, improving healthcare accessibility and patient engagement. |
Regional Scope |
North America, Europe, APAC, South
America and Middle East and Africa |
Country Scope |
U.S.; Canada;
U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia;
China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico;
Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria |
Key Companies |
NioyaTech, Syntegra, Oracle, Tencent
Holdings Ltd., Neuralink Corporation, Johnson & Johnson, IBM Watson,
Saxon, OpenAI, Google LLC and Microsoft Corporation and other. |
Market Dynamics
Market Drivers
The
Growing Utilization Of Artificial Intelligence Within The Healthcare Sector Is
On The Rise
The
increased integration of artificial intelligence (AI) in healthcare is
significantly boosting the expansion of the Generative AI in Healthcare Market.
AI, particularly Generative AI, demonstrates vast potential in transforming
healthcare by aiding in various areas like drug discovery, personalized
medicine, and medical imaging analysis. Generative AI's capacity to simulate
and generate new data, such as molecular structures for drug development or
medical images for diagnostics, plays a crucial role in expediting research and
development.
The
application of Generative AI allows healthcare professionals to explore
extensive datasets, identify patterns, and create inventive solutions that were
previously unattainable through traditional approaches. These technologies
contribute to predicting patient outcomes, refining treatment plans, and
enhancing overall patient care. The integration of AI in healthcare has
resulted in improved efficiency, decreased operational expenses, and enhanced
accuracy in diagnoses and treatment decisions, thus fueling the demand for
Generative AI solutions in the healthcare sector. Additionally, the ongoing
progress in AI algorithms and computing capabilities further promotes the
creation and implementation of Generative AI applications in healthcare,
fostering innovation and leading to substantial growth within the healthcare AI
market.
The
Process Of Identifying And Creating New Pharmaceutical Compounds And Medicines
The
advancement of Generative AI in healthcare significantly fuels the progress of
drug discovery and development, particularly within the Generative AI in
Healthcare Market. Generative AI holds a pivotal role in hastening the drug
development process by presenting innovative solutions that aid in generating
and refining new compounds. Traditional drug discovery involves a
time-intensive and expensive screening of a vast compound library to identify
potential candidates. Generative AI, however, has the capability to rapidly
analyze extensive datasets, forecast molecular structures, and suggest
potential drug candidates through virtual simulations and algorithms.
The
incorporation of Generative AI enables pharmaceutical companies and research
institutions to streamline the initial phases of drug discovery. These
AI-powered tools assist in producing molecular structures, predicting their
characteristics, and proposing modifications, thereby reducing the time and
resources needed to identify promising drug candidates. Furthermore, these
technologies contribute to refining the synthesis process, anticipating
potential side effects, and enhancing the overall success rate of drug
development endeavors. Consequently, the integration of Generative AI in drug
discovery and development not only expedites the process but also enhances the
efficiency and accuracy of identifying potential therapeutic agents. This
drives the expansion of the healthcare AI market.
Market Restrains
Issues
Surrounding The Protection And Safeguarding Of Personal Information And The
Security Of Data
The
sensitive nature of healthcare data, encompassing patient records, medical
images, and treatment histories, there is a significant worry regarding the
safeguarding and potential misuse of this information. The use of Generative AI
involves extensive data processing and analysis, leading to increased risks of
unauthorized access, breaches, and unintentional exposure of patients' personal
health information. Complying with strict regulations such as the Health
Insurance Portability and Accountability Act (HIPAA) and other data protection
laws adds an additional layer of complexity, necessitating adherence to
specific standards for data security.
The
absence of standardized protocols and clear guidelines for securing
AI-generated insights, coupled with ethical considerations related to patient
consent and algorithmic biases, further contributes to the hesitancy in
embracing Generative AI in healthcare. To address these concerns and promote
broader adoption, it is imperative to implement robust security measures,
establish clear regulatory frameworks, and adopt proactive strategies to
enhance data protection and privacy, thereby building trust within the
healthcare industry.
Market By Function Analysis
By
Function, the Generative AI in Healthcare Market is Categories into Virtual
Nursing Assistants, Image Analysis, Aid Clinical Judgment/Diagnosis, Workflow
& Administrative Tasks, AI-Assisted Robotic Surgery. The Image Analysis
segment accounts for the largest share of around 47% in 2022.
Generative
AI methods are applied to elevate the quality and precision of medical images.
Through the generation of synthetic images, these AI models can heighten
clarity, diminish noise, and refine the details of medical images gathered from
diverse modalities like MRI, CT scans, ultrasound, and X-rays.
Market By Application Analysis
By
Application, the Generative AI in Healthcare Market is Categories into System
and Clinical. The Clinical segment accounts for the largest share of around 54%
in 2022.
The
expansion within this sector is credited to the utilization of generative AI
across diverse domains in the healthcare realm. Generative AI finds application
in enhancing medical imaging within fields like radiology and pathology. Its
capability to produce synthetic images mimicking various conditions serves to
enhance image quality and assist in the examination and understanding of
medical images.
Market By End User Analysis
By
End User, the Generative AI in Healthcare Market is Categories into Clinical
Research, Hospitals & Clinics, Diagnostic Centers, Healthcare Organizations
and Others. The Diagnostic Centers segment accounts for the largest share of
around 53% in 2022. Generative AI serves as a support tool for radiologists and
other healthcare practitioners in interpreting medical images. Through training
on extensive datasets of labeled images, generative AI models can acquire the
ability to identify and categorize abnormalities, contributing to the diagnosis
of various conditions. This function contributes significantly to the market's
growth and advancement.
Market Regional Analysis
North
America dominate the Generative AI in Healthcare Market with the highest
revenue generating market with share of more than 51%. The expansion in this
area is credited to the increasing uptake of generative AI within healthcare
institutions. North American healthcare facilities, encompassing hospitals,
clinics, and diagnostic centers, are progressively acknowledging the potential
of generative AI and incorporating it into their operations. Generative AI is
being utilized in diverse clinical sectors, like radiology, pathology, and
cardiology, to boost diagnostic precision, refine treatment strategies, and
enhance patient results.
Europe
is second largest market in Generative AI in Healthcare Market with share of
more than 34%. Â The rapid growth in
Europe is propelled by robust government support, prominent research
institutions, a solid healthcare infrastructure, and an increasing need for
personalized and precision medicine.
In
the Asia Pacific region is a fastest growing region in forecasted periods. The
significant factors contributing to this trend are the region's substantial and
varied patient population and the rising government initiatives. With a large
and diverse patient demographic, there's an abundance of data available for
training generative AI models. This diversity in data resources allows for the
creation of strong and precise generative AI algorithms, ultimately resulting
in enhanced diagnosis, treatment planning, and better patient outcomes.
Competitive Analysis
The
Generative AI in Healthcare Market is dominated by a few large companies, such
as NioyaTech, Syntegra, Oracle, Tencent Holdings Ltd., Neuralink Corporation,
Johnson & Johnson, IBM Watson, Saxon, OpenAI, Google LLC and Microsoft
Corporation and other.
There Are Some Of The Key Trends That Are Shaping The
Competitive Landscape Of The Generative AI In Healthcare industry
April
2023, Microsoft revealed intentions to integrate generative AI into clinical
software provided by Epic, which is the largest Electronic Health Record (EHR)
vendor in the United States. The collaboration between the two companies led to
the introduction of initial sites incorporating GPT (Generative Pre-Trained
Transformer) into EHR workflows. This integration enables the automatic
drafting of responses to patient messages. Furthermore, the collaboration aims
to introduce genAI into Epic's hospital database, enabling non-specialists to
pose general questions to AI without requiring the expertise of a data
scientist to query specific data.
Research Report Following Segments:
Market, By Function
·       Â
Virtual Nursing
Assistants
·       Â
Image Analysis
·       Â
Aid Clinical
Judgment/Diagnosis
·       Â
Workflow &
Administrative Tasks
·        AI-Assisted Robotic Surgery
Market, By Application
·       Â
System
·       Â
Clinical
Market, By End User
·       Â
Clinical Research
·       Â
Hospitals & Clinics
·       Â
Diagnostic Centers
·       Â
Healthcare Organizations
·       Â
Others
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Generative AI in Healthcare Market was valued at USD 1,593 million in 2022.
Generative AI in Healthcare Market size will increase at approximate CAGR of 37.2% during the forecasted period.
Major companies operating within the Generative AI in Healthcare Market are NioyaTech, Syntegra, Oracle, Tencent Holdings Ltd., Neuralink Corporation, Johnson & Johnson, IBM Watson, Saxon, OpenAI, Google LLC and Microsoft Corporation and other.
North America dominates the market with an active share of 51%.
Only Three Thousand Four Hundred Ninety Nine US dollar
Only Four Thousand Four Hundred Ninety Nine US dollar
Only Five Thousand Four Hundred Ninety Nine US dollar